INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Why Biotech (gene therapy) investors are about to lose their shirts—shhh, don't tell J P Morgan

Why Biotech (gene therapy) investors are about to lose their shirts—shhh, don't tell J P Morgan

Not for the first time, investors behave like sheep

Hedley Rees's avatar
Hedley Rees
Oct 24, 2024
∙ Paid
24

Share this post

INSIDE PHARMA
INSIDE PHARMA
Why Biotech (gene therapy) investors are about to lose their shirts—shhh, don't tell J P Morgan
9
5
Share

Recycling this from August just gone

Alan Richards, a regular and welcome commenter on INSIDE PHARMA, set me in mind to recycle the post. This is his comment:

“Starboard is an activist investor. They claim to make profits from over 80% of their campaigns. Maybe you should offer your services Hedley.

https://www.starboardvalue.com/contact/”

This is my answer:

“They would need to recognise the value in speaking to me, Alan, and of course, they wouldn't. I feel sorry for any investors that are listening to them. In fact, I feel sorry for anyone investing in today's big pharma smoke and mirrors - the bubble is set to burst. You might check this out: https://open.substack.com/pub/hedleyrees/p/why-biotech-gene-therapy-investors?r=xoehy&utm_campaign=post&utm_medium=web”

This is the post, recycled, and free:

Not for the first time, investors behave like sheep

The dot-com bubble is a warning from history that investors can behave like sheep, and end up as lemmings, tumbling off a very high cliff. For …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share